Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

Y Li, Y Liu, S Liu, M Gao, W Wang, K Chen… - Signal transduction and …, 2023 - nature.com
Vascular complications of diabetes pose a severe threat to human health. Prevention and
treatment protocols based on a single vascular complication are no longer suitable for the …

Molecular aspects of fructose metabolism and metabolic disease

MA Herman, MJ Birnbaum - Cell metabolism, 2021 - cell.com
Excessive sugar consumption is increasingly considered as a contributor to the emerging
epidemics of obesity and the associated cardiometabolic disease. Sugar is added to the diet …

Hyperuricemia and its related diseases: mechanisms and advances in therapy

L Du, Y Zong, H Li, Q Wang, L Xie, B Yang… - … and Targeted Therapy, 2024 - nature.com
Hyperuricemia, characterized by elevated levels of serum uric acid (SUA), is linked to a
spectrum of commodities such as gout, cardiovascular diseases, renal disorders, metabolic …

[HTML][HTML] Uric acid and cardiovascular disease: a clinical review

Y Saito, A Tanaka, K Node, Y Kobayashi - Journal of cardiology, 2021 - Elsevier
Uric acid, the end-product of purine metabolism in humans, is not only a cause of gout, but
also may play roles in developing cardiovascular diseases such as hypertension, atrial …

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

LA Inker, W Collier, T Greene, S Miao, J Chaudhari… - Nature medicine, 2023 - nature.com
Glomerular filtration rate (GFR) decline is causally associated with kidney failure and is a
candidate surrogate endpoint for clinical trials of chronic kidney disease (CKD) progression …

[HTML][HTML] Uric acid in inflammation and the pathogenesis of atherosclerosis

Y Kimura, D Tsukui, H Kono - International journal of molecular sciences, 2021 - mdpi.com
Hyperuricemia is a common metabolic syndrome. Elevated uric acid levels are risk factors
for gout, hypertension, and chronic kidney diseases. Furthermore, various epidemiological …

Serum urate lowering with allopurinol and kidney function in type 1 diabetes

A Doria, AT Galecki, C Spino… - … England Journal of …, 2020 - Mass Medical Soc
Background Higher serum urate levels are associated with an increased risk of diabetic
kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in …

Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care

HK Choi, N McCormick, C Yokose - Nature Reviews Rheumatology, 2022 - nature.com
Gout is a common hyperuricaemic metabolic condition that leads to painful inflammatory
arthritis and a high comorbidity burden, especially cardiometabolic-renal (CMR) conditions …

KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease

PE Stevens, SB Ahmed, JJ Carrero… - Kidney …, 2024 - kidney-international.org
This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Comparative Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and …

N McCormick, C Yokose, J Wei, N Lu… - Annals of Internal …, 2023 - acpjournals.org
Background: Sodium–glucose cotransporter-2 inhibitors (SGLT2is) decrease serum urate
levels, but whether this translates into prevention of recurrent flares among patients with …